This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Endurance Stack
Oxygen Utilization / Mitochondrial Efficiency / Fatigue Resistance / Lowered Perception of Effort
Overview
What is Endurance Stack?
Sean's 'good endurance stack' — a 4-compound community protocol combining Meldonium (metabolic shift to glucose), ITPP (hemoglobin oxygen-release enhancer), Bromantane (adaptogenic dopamine support), and Methylene Blue (mitochondrial electron carrier). Built around Sean's framing that real endurance is NOT 'more energy / more stimulation' — it should prioritize better oxygen use, cleaner energy production, lowered perception of effort, smoother nervous system output, and better recovery.
Key Benefits
Improved oxygen extraction at the tissue level (less 'gasping for air' at exhaustion), shifted energy metabolism toward more oxygen-efficient glucose oxidation, reduced central fatigue, increased willingness to sustain effort with calmer emotional state, and improved mitochondrial ATP output under sustained load. Targeted at researchers studying athletic, MMA, and active-subject performance contexts.
Mechanism of Action
Four converging endurance levers, each at a different layer: (1) Meldonium inhibits carnitine biosynthesis, downregulating fatty acid oxidation and shifting metabolism toward glucose — which requires LESS oxygen per ATP than fat. (2) ITPP allosterically modifies hemoglobin so RBCs release oxygen to tissues more readily (EPO-adjacent mechanism, opposite end of the chain from EPO). (3) Bromantane upregulates tyrosine hydroxylase → dopamine synthesis, supporting drive + stress resilience without sympathetic spiking. (4) Methylene Blue acts as an alternative electron carrier in the mitochondrial ETC, bypassing electron 'backup' under exercise stress and enhancing cerebral oxygen utilization.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.